Advertisement

Topics

Proclara Biosciences Australia, a Subsidiary of Proclara Biosciences, Awarded Grant by Biopharmaceuticals Australia to Help Develop New Biotherapy with Blockbuster Potential

08:00 EST 10 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Proclara Biosciences, a biotechnology company developing novel therapies for diseases caused by protein misfolding, announced today that it has been awarded a grant of $250,000 to support the development of NPT189 for the treatm...

Other Sources for this Article

Media:
Ten Bridge Communications
Sarah Sutton, 857-242-1619
Sarah@tenbridgecommunications.com
or
Investor Relations:
Stern Investor Relations, Inc.
Hannah Deresiewicz, 212-362-1200
hannahd@sternir.com

NEXT ARTICLE

More From BioPortfolio on "Proclara Biosciences Australia, a Subsidiary of Proclara Biosciences, Awarded Grant by Biopharmaceuticals Australia to Help Develop New Biotherapy with Blockbuster Potential"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...